GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stoke Therapeutics Inc (STU:0GT) » Definitions » Net Interest Income (for Banks)

Stoke Therapeutics (STU:0GT) Net Interest Income (for Banks)


View and export this data going back to 2019. Start your Free Trial

What is Stoke Therapeutics Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Stoke Therapeutics (STU:0GT) Business Description

Industry
Traded in Other Exchanges
Address
45 Wiggins Avenue, Bedford, MA, USA, 01730
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. The company primarily operates in the U.S.